Talos Eurisko Asset Management LP purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the second quarter, Holdings Channel.com reports. The firm purchased 33,300 shares of the semiconductor company’s stock, valued at approximately $17,072,000. Synopsys makes up approximately 4.1% of Talos Eurisko Asset Management LP’s investment portfolio, making the stock its 13th biggest position.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC increased its holdings in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares in the last quarter. Kingsview Wealth Management LLC increased its stake in shares of Synopsys by 28.2% during the 1st quarter. Kingsview Wealth Management LLC now owns 722 shares of the semiconductor company’s stock worth $310,000 after purchasing an additional 159 shares during the last quarter. Kestra Private Wealth Services LLC grew its stake in shares of Synopsys by 7.7% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,229 shares of the semiconductor company’s stock worth $2,242,000 after acquiring an additional 376 shares during the period. Gallacher Capital Management LLC grew its stake in Synopsys by 11.3% in the 1st quarter. Gallacher Capital Management LLC now owns 520 shares of the semiconductor company’s stock valued at $223,000 after buying an additional 53 shares in the last quarter. Finally, Crestwood Advisors Group LLC bought a new stake in shares of Synopsys during the 1st quarter valued at $269,000. Institutional investors own 85.47% of the company’s stock.
Insider Activity
In related news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. The trade was a 32.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. The trade was a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 30,894 shares of company stock valued at $16,760,783 over the last 90 days. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter last year, the company earned $3.43 earnings per share. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on SNPS shares. The Goldman Sachs Group decreased their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Wells Fargo & Company decreased their price objective on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a report on Wednesday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Citigroup downgraded shares of Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Finally, Baird R W downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Synopsys currently has a consensus rating of “Hold” and an average price target of $562.14.
Check Out Our Latest Research Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- The Role Economic Reports Play in a Successful Investment Strategy
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- High Dividend REITs: Are They an Ideal Way to Diversify?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- How to Capture the Benefits of Dividend Increases
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
